查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
自订抗体的到市场规模，占有率，趋势分析:各类型，各类服务，各原料，各研究领域，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测
市场调查报告书
商品编码
1070364

自订抗体的到市场规模，占有率，趋势分析:各类型，各类服务，各原料，各研究领域，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测

Custom Antibody Market Size, Share & Trends Analysis By Type, By Service, By Source, By Research Area, By End-User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 228 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球自订抗体的市场规模，预计今后以9.4％的年复合成长率扩大，至2030年达到8亿8,960万美元。产学联合增加，生命科学产业为中心的研究活动的活跃，是市场扩大的原动力。

本报告提供全球自订抗体市场相关调查，市场概要，以及各类型，各类服务，各原料，各研究领域，各终端用户，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场动态

  • 成长要素，阻碍因素，机会，课题的分析
    • 促进因素
    • 阻碍因素
    • 市场机会
    • 课题
  • 自订抗体市场的COVID-19影响

第5章 市场变数及预测

  • SWOT分析
    • 优势
    • 弱点
    • 机会
    • 威胁
  • PESTEL分析
    • 政治形势
    • 经济形势
    • 社会形势
    • 技术形势
    • 环境形势
    • 法律上的形势
  • 波特的五力分析
    • 卖主谈判力
    • 买方议价能力
    • 替代威胁
    • 新加入厂商的威胁
    • 竞争企业间的敌对关係
  • 热图分析

第6章 全球自订抗体市场，各类型，2019年～2030年(100万美元)

  • 单株抗体
  • 其他的自订抗体
  • 多株抗体
  • 重组抗体

第7章 全球自订抗体市场，各类服务，2019年～2030年(100万美元)

  • 抗体开发
  • 抗体的生产与精製
  • 抗体的片断化和标记

第8章 全球自订抗体市场，各原料，2019年～2030年(100万美元)

  • 鼠
  • 兔
  • 其他

第9章 全球自订抗体市场，各研究领域，2019年～2030年(100万美元)

  • 循环系统疾病
  • 免疫学
  • 感染疾病
  • 神经生物学
  • 肿瘤学
  • 其他
  • 干细胞

第10章 全球自订抗体市场，各终端用户，2019年～2030年(100万美元)

  • 学术研究
  • CRO
  • 製药公司，生物科技企业

第11章 全球自订抗体市场，各地区，2019年～2030年(100万美元)

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 中东、非洲
    • 沙乌地阿拉伯王国
    • 阿拉伯联合大公国
    • 其他

第12章 企业简介

  • BioLegend
  • Bio-Rad Laboratories, Inc
  • Cell Signaling Technology, Inc.
  • GenScript
  • Merck Group
  • Rockland Immunochemicals
  • Thermo Fisher Scientific, Inc
简介目录
Product Code: BIOT2214

Global Custom Antibody Market projected to be worth USD 889.6 million by 2030.

According to SPER Market Research, the Custom Antibody Market estimated to reach USD 889.6 million by 2030 with a CAGR of 9.4%.

Increasing industry-academia collaborations, growing research activity particularly in the life sciences industry; are the key that impel the market expansion.

Impact of COVID-19 on the Custom Antibody Market

Increase in research activities, availability of funding for research and the demand for antibodies, pharmaceutical companies, and small start-ups, has taken step to develop treatments and vaccines that target the infection. So there is a positive impact in this custom antibody market.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered By Type, By Service, By Source, By Research Area, By End-User, By Region

  • Geographies covered : North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: BioLegend, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., GenScript, Merck Group, Rockland Immunochemicals, Thermo Fisher Scientific, Inc.

Driver: growing research activities and funding

Growing research activities and funding, quality concerns over catalogue antibodies, increasing industry-academia collaborations, rising focus on therapeutic antibodies and extensive pipeline drugs; are the key factors that drive the market expansion.

Restraint:

Antibody development is a costly and time consuming process that resists the market expansion.

Opportunity: Increasing demand for personalized medicine in protein therapeutics

Growing demand for personalized medicine in protein therapeutics, rising focus on biomarker discovery, high growth opportunities in developing countries.

Challenges: Presence of Alternative Antibodies

Availability of alternative antibodies in the market that is a challenge to the custom antibody market expansion.

Global Custom Antibody Market, By Type:

Based on the Type, Global Custom Antibody Market is segmented as; Monoclonal Antibodies, Other Custom Antibodies, Polyclonal Antibodies, Recombinant Antibodies.

Global Custom Antibody Market, By Service:

Based on the Service, Global Custom Antibody Market is segmented as; Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling.

Global Custom Antibody Market, By Source:

Based on the Source, Global Custom Antibody Market is segmented as; Mice, Rabbits, Other Sources.

Global Custom Antibody Market, By Research Area:

Based on the Research Area, Global Custom Antibody Market is segmented as; Cardiovascular Disease, Immunology, Infectious Diseases, Neurobiology, Oncology, Other Research Areas, Stem Cells.

Global Custom Antibody Market, By End-User:

Based on the End-User, Global Custom Antibody Market is segmented as; Academic & Research Institutes, Contract Research organizations, Pharmaceutical & Biotechnology Companies.

Global Custom Antibody Market, By Region:

North America owns the biggest share of the Global Custom Antibody Market; this is because of increasing research in the fields of genomics and proteomics, antibody-based therapeutics. The growing investments in the development of structure-based drug designs, and growing demand for high-quality research tools for data reproducibility.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Custom Antibody Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Custom Antibody Market, By Type, 2019-2030 (USD Million)

  • 6.1. Monoclonal Antibodies
  • 6.2. Other Custom Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Global Custom Antibody Market, By Service, 2019-2030 (USD Million)

  • 7.1. Antibody Development
  • 7.2. Antibody Production & Purification
  • 7.3. Antibody Fragmentation & Labeling

8. Global Custom Antibody Market, By Source, 2019-2030 (USD Million)

  • 8.1. Mice
  • 8.2. Rabbits
  • 8.3. Other Sources

9. Global Custom Antibody Market, By Research Area, 2019-2030 (USD Million)

  • 9.1. Cardiovascular Disease
  • 9.2. Immunology
  • 9.3. Infectious Diseases
  • 9.4. Neurobiology
  • 9.5. Oncology
  • 9.6. Other Research Areas
  • 9.7. Stem Cells

10. Global Custom Antibody Market, By End-User, 2019-2030 (USD Million)

  • 10.1. Academic & Research Institutes
  • 10.2. Contract Research organizations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Global Custom Antibody Market, By Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

12. 1. BioLegend

    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Bio-Rad Laboratories, Inc.
  • 12.3. Cell Signaling Technology, Inc.
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. GenScript
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments

12. 5. Merck Group

    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments

12. 6. Rockland Immunochemicals

    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments

12. 7. Thermo Fisher Scientific, Inc

    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments